Business
Nigerian biotech startup becomes first African lab to offer liquid biopsy to advance cancer diagnosis
Nigeria-based biotechnology startup, Syndicate Bio. has partnered with SophiaGenetics, a cloud-native software firm specializing in data-driven medicine, to become the inaugural laboratory in Africa to offer comprehensive genomic profiling and liquid biopsy services on a continent-wide scale.
The partnership marks a significant milestone in Africa’s healthcare landscape, promising unprecedented access to cutting-edge genomic technologies previously unavailable to patients across the continent.
By leveraging Sophia Genetics’ expertise in cloud-based healthcare solutions, Syndicate Bio aims to democratize genetic testing and empower healthcare providers with advanced diagnostic capabilities.
According to the Chief Medical Officer of SOPHiA Genetics’, who highlighted the laboratory’s role in shaping global healthcare through the creation of comprehensive datasets, the significance of this partnership extends beyond immediate clinical impact.
By leveraging data insights, the collaboration aims to drive innovation, accelerate drug discovery, and ultimately improve health outcomes worldwide.
- News9 months ago
British Council Hikes IELTS Fees in Nigeria: Here’s Why
- Politics7 months ago
Why I want to be the next governor of Kogi State – ADC’s Abejide
- Politics8 months ago
“Should Atiku Call Tinubu to Remove Wike as FCT Minister, He Will be Sacked” – Bwala Reveals
- News8 months ago
It’ll take Nigeria 20 years to produce enough doctors, pharmacists, others – Stakeholders
- News9 months ago
DS Kalu – We Will provide legal framework to boost direct foreign investments
- Business9 months ago
FG to Fast-Track AfDB’s SAPZ Project to Boost Agricultural Growth
- Investigation9 months ago
NDLEA chiefs accused of N3.7m bribery
- News9 months ago
Woman killed in Benin after overhead water tank collapses